Genocea Biosciences
GNCA
#10143
Rank
A$0 M
Marketcap
$0.0001536
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)

Genocea Biosciences (GNCA) - Cash on Hand

Cash on Hand as of March 2022 : A$30.92 Million

According to Genocea Biosciences 's latest financial reports the company has A$30.92 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Genocea Biosciences - Cash on Hand chart (from 2012 to 2022)

Cash on Hand by year

Year Cash on Hand Change
2021-12-31A$51.24 M-50.61%
2020-12-31A$0.10 B81.01%
2019-12-31A$57.31 M53.16%
2018-12-31A$37.41 M138.03%
2017-12-31A$15.72 M-82.12%
2016-12-31A$87.9 M-32.11%
2015-12-31A$0.12 B125.09%
2014-12-31A$57.52 M320.31%
2013-12-31A$13.68 M23.51%
2012-12-31A$11.08 M97.88%
2011-12-31A$5.6 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.14 B 365.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.61 B 5,112.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$22.41 B 72,368.59%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.82 M-29.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.28 B 49,321.46%๐Ÿ‡บ๐Ÿ‡ธ USA